Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome
- PMID: 1338906
- DOI: 10.1093/hmg/1.5.301
Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome
Abstract
The Denys-Drash syndrome is characterised by a typical nephropathy, genital abnormalities and also predisposes to the development of Wilms' tumor. These patients eventually go into end stage renal failure. A candidate Wilms' tumor gene, WT1, from the 11p13 chromosome region has recently been cloned. We have analysed the DNA sequence in constitutional cells from eight patients and have shown heterozygous mutations in six of them. Four of the mutations were in exon 9, all resulting in missense mutations. Three were at nucleotide position 1180 resulting in an arg > trp amino acid change. The other was at position 1186 converting an asp > asn in the predicted resultant protein. One patient had a missense mutation in exon 8, converting an arg > his. A single base pair insertion at nucleotide position 821 in exon 6 resulted in the generation of a premature stop codon in the last patient. We were unable to find a mutation in one patient despite complete sequencing of the genomic sequence of the gene. The last patient carried a constitutional deletion of the 11p13 region and no additional mutation was found. There was no obvious correlation between the type of mutation and phenotypic expression. These results further demonstrate that the WT1 gene is important in both the development of the kidney and the genito-urinary system.
Similar articles
-
The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.Hum Mutat. 1999;13(2):146-53. doi: 10.1002/(SICI)1098-1004(1999)13:2<146::AID-HUMU7>3.0.CO;2-I. Hum Mutat. 1999. PMID: 10094551
-
A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.FEBS Lett. 1993 Feb 8;317(1-2):39-43. doi: 10.1016/0014-5793(93)81487-k. FEBS Lett. 1993. PMID: 8381368
-
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o. Biochemistry. 1996. PMID: 8810912
-
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.Hum Mol Genet. 1992 Aug;1(5):293-5. doi: 10.1093/hmg/1.5.293. Hum Mol Genet. 1992. PMID: 1338905 Review. No abstract available.
-
[Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].Nihon Rinsho. 1995 Nov;53(11):2742-8. Nihon Rinsho. 1995. PMID: 8538037 Review. Japanese.
Cited by
-
Atypical clinical presentation of a WT1-related syndrome associated with a novel exon 6 gene mutation.BMJ Case Rep. 2013 May 27;2013:bcr2013009543. doi: 10.1136/bcr-2013-009543. BMJ Case Rep. 2013. PMID: 23715837 Free PMC article.
-
WT1-related disorders: more than Denys-Drash syndrome.Pediatr Nephrol. 2024 Sep;39(9):2601-2609. doi: 10.1007/s00467-024-06302-y. Epub 2024 Feb 7. Pediatr Nephrol. 2024. PMID: 38326647 Review.
-
Molecular genetic analysis of chromosome 11p in familial Wilms tumour.Br J Cancer. 1994 Jun;69(6):1072-7. doi: 10.1038/bjc.1994.210. Br J Cancer. 1994. PMID: 7911030 Free PMC article.
-
Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.Br J Cancer. 1993 Jun;67(6):1259-61. doi: 10.1038/bjc.1993.235. Br J Cancer. 1993. PMID: 8390282 Free PMC article.
-
Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):11960-4. doi: 10.1073/pnas.92.26.11960. Proc Natl Acad Sci U S A. 1995. PMID: 8618823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases